Why Greenwich LifeSciences Stock Is Trading Higher Today

Greenwich LifeSciences GLSI shares are trading higher on Wednesday after the company announced the publication of an abstract at the San Antonio Breast Cancer Symposium of Phase IIb trial data for GP2.

Greenwich LifeSciences is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.

Greenwich LifeSciences shares were trading up 16.59% at $4.85 at last check Wednesday. The stock has a 52-week range between $5.75 and $3.26.